Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-Human Investigational Testing Authorization Study Evaluating the Safety and Performance of the Vesalius Transcatheter Mitral Valve Repair System in Patients With Severe, Symptomatic Degenerative Mitral Regurgitation

NCT07470788 is registered in ClinicalTrials.gov with Vesalius Cardiovascular Inc. as lead sponsor.

NCT NCT07470788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07470788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-Human Investigational Testing Authorization Study Evaluating the Safety and Performance of the Vesalius Transcatheter Mitral Valve Repair System in Patients With Severe, Symptomatic Degenerative Mitral Regurgitation
Lead sponsor
Vesalius Cardiovascular Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
August 31, 2026
Completion date
April 30, 2032
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative mitral regurgitation